TIMM8A and lung adenocarcinoma: The expression differences of TIMM8A in BLCA (bladder urothelial carcinoma), BRCA, CESC (cervical and endocervical cancer), COAD (colon adenocarcinoma), ESCA (esophageal carcinoma), HNSC (head and neck cancer), KICH (kidney chromophobe), KIRC (kidney renal clear cell carcinoma), LIHC (liver hepatocellular carcinoma), LUAD (lung adenocarcinoma), LUSC (lung squamous cell carcinoma), PRAD (prostate adenocarcinoma), READ (rectum adenocarcinoma), STAD (stomach adenocarcinoma), UCEC, and corresponding normal tissues were statistically significant (Fig. 1).